Sixuan Qian

2.9k total citations
154 papers, 2.1k citations indexed

About

Sixuan Qian is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Sixuan Qian has authored 154 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Hematology, 57 papers in Immunology and 47 papers in Molecular Biology. Recurrent topics in Sixuan Qian's work include Acute Myeloid Leukemia Research (46 papers), Immunotherapy and Immune Responses (37 papers) and T-cell and B-cell Immunology (27 papers). Sixuan Qian is often cited by papers focused on Acute Myeloid Leukemia Research (46 papers), Immunotherapy and Immune Responses (37 papers) and T-cell and B-cell Immunology (27 papers). Sixuan Qian collaborates with scholars based in China, United States and Taiwan. Sixuan Qian's co-authors include Liwei Lu, Angus W. Thomson, Jianyong Li, John J. Fung, William A. Rudert, Ming Hong, David H. Lynch, Pamela A. Hershberger, Chun Qiao and A S Rao and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Sixuan Qian

143 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sixuan Qian China 25 893 754 496 321 293 154 2.1k
Fumihiko Kimura Japan 21 781 0.9× 700 0.9× 520 1.0× 438 1.4× 270 0.9× 138 2.1k
Yubin Kang United States 24 459 0.5× 748 1.0× 457 0.9× 614 1.9× 133 0.5× 97 1.9k
Masaaki Higashihara Japan 25 542 0.6× 675 0.9× 412 0.8× 477 1.5× 105 0.4× 127 2.1k
A Kanamaru Japan 25 785 0.9× 531 0.7× 1.0k 2.1× 512 1.6× 87 0.3× 84 2.1k
G Isacchi Italy 20 413 0.5× 440 0.6× 685 1.4× 241 0.8× 161 0.5× 75 1.6k
C. Darrell Jennings United States 20 602 0.7× 450 0.6× 707 1.4× 299 0.9× 102 0.3× 58 1.8k
Depei Wu China 28 671 0.8× 948 1.3× 1.6k 3.2× 958 3.0× 121 0.4× 219 3.0k
Gianfranco Mattia Italy 28 440 0.5× 1.4k 1.8× 476 1.0× 361 1.1× 99 0.3× 54 2.4k
Simi Ali United Kingdom 30 828 0.9× 707 0.9× 110 0.2× 765 2.4× 491 1.7× 105 2.4k
T Sato United States 19 837 0.9× 402 0.5× 840 1.7× 314 1.0× 87 0.3× 40 1.8k

Countries citing papers authored by Sixuan Qian

Since Specialization
Citations

This map shows the geographic impact of Sixuan Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixuan Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixuan Qian more than expected).

Fields of papers citing papers by Sixuan Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixuan Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixuan Qian. The network helps show where Sixuan Qian may publish in the future.

Co-authorship network of co-authors of Sixuan Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Sixuan Qian. A scholar is included among the top collaborators of Sixuan Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sixuan Qian. Sixuan Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Miaomiao, Ting Luo, Jialin Cui, et al.. (2025). Prediction of survival in acute myeloid leukemia patients by extracellular to intracellular water ratio and sarcopenia: development and validation of a novel nomogram. Annals of Hematology. 104(2). 985–996. 1 indexed citations
2.
Sun, Qian, Jialin Cui, Wenjie Liu, et al.. (2022). The Prognostic Value of Sarcopenia in Acute Myeloid Leukemia Patients and the Development and Validation of a Novel Nomogram for Predicting Survival. Frontiers in Oncology. 12. 828939–828939. 9 indexed citations
3.
Li, Lan‐Zhu, Qian Sun, Lijia Yang, et al.. (2020). A report on Lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia. Chinese Medical Journal. 133(16). 2001–2003. 8 indexed citations
4.
Hong, Ming, Han Zhu, Qian Sun, et al.. (2020). Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML. Aging. 12(7). 5792–5811. 21 indexed citations
5.
Li, Shan, Chun Qiao, Lijia Yang, et al.. (2019). Fumarate hydratase deficiency induces chronic myeloid leukemia progression. Translational Cancer Research. 8(2). 592–602. 1 indexed citations
6.
Xu, Min, Xiaoli Zhao, Wenyi Shen, et al.. (2018). ND4 mutations are more prevalent in patients with acute myeloid leukemia of M2 morphology. Translational Cancer Research. 7(4). 1064–1071. 1 indexed citations
7.
10.
Fan, Lei, Li Wang, Yujie Wu, et al.. (2015). MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients. Tumor Biology. 37(1). 1237–1244. 7 indexed citations
12.
Ma, Lingdi, Xuzhang Lu, Zhichao Zhu, et al.. (2013). [Effects of matrine on the expression of NKG2D ligands in leukemia cells].. PubMed. 21(6). 1429–34. 1 indexed citations
13.
Sun, Haiming, Sixuan Qian, & Jianyong Li. (2009). [Advance of study on MN1 gene in acute myeloid leukemia - review].. PubMed. 17(2). 504–8. 1 indexed citations
14.
Li, Jianyong, Wei Xu, Wei Wu, et al.. (2008). The Negative Prognostic Impact of Derivative 9 Deletions in Patients Who Received Hydroxyurea Treatment for Chronic Myelogenous Leukemia in the Chronic Phase. Oncology Research and Treatment. 31(11). 585–589. 3 indexed citations
15.
Chen, Liang‐Jwu, et al.. (2007). Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.. PubMed. 29(4). 299–303. 3 indexed citations
16.
Lu, Liwei, et al.. (2001). CTLA4-Ig inhibits rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with increased lymphocyte apoptosis. Transplantation Proceedings. 33(1-2). 246–247. 2 indexed citations
18.
Lu, Liwei, Andrea Gambotto, Sixuan Qian, et al.. (1999). Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Therapy. 6(4). 554–563. 83 indexed citations
19.
Fu, F, et al.. (1999). Treatment with CTLA4-Ig inhibits rejection of liver allografts from Flt3-ligand–treated donors. Transplantation Proceedings. 31(1-2). 453–453. 5 indexed citations
20.
Steptoe, Raymond J., F Fu, Liwei Lu, et al.. (1997). Donor pretreatment with Flt3 ligand augments liver and heart dendritic cell number and exacerbates allograft rejection. Journal of Allergy and Clinical Immunology. 99. 1957–1957. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026